Australian Office REITs Stock News

Founder‑led companies can be especially interesting when markets are being pulled around by inflation headlines, energy shocks, and shifting rate expectations. While central banks, bond yields, and commodity prices keep moving, founders with meaningful ownership have a clear incentive to focus on capital efficiency and long‑term value creation rather than short‑term optics. This screener filters for exactly that, leaders with real skin in the game and tight control on how each dollar of...

Why ANZ’s latest earnings and leadership moves matter now ANZ Group Holdings (ASX:ANZ) has drawn extra attention after delivering stronger earnings than some peers during the recent reporting season, prompting broker reassessments and lifting sentiment around the bank’s stock. At the same time, ANZ confirmed Michael Peric and Trevor Vail as co-Managing Directors of its Markets business, formalising a leadership structure they had been filling in an acting capacity since September 2025. See...

In recent weeks, Generation Development Group issued 46,384 new ordinary shares on the ASX under its distribution plan, while also reporting a profit collapse in which net income fell by very large double‑digit percentages compared with the prior period. This combination of equity issuance and a sharp earnings setback has prompted investors to reassess the company’s earnings stability, dividend outlook, and capacity to reinvest for growth. We’ll now examine how this profit collapse, despite...

EBITDA jump and cost gains put PLS Group (ASX:PLS) in focus PLS Group (ASX:PLS) has drawn fresh attention after reporting a very large increase in underlying EBITDA, supported by higher lithium prices and operational efficiencies that lowered unit operating costs by 8%. See our latest analysis for PLS Group. The recent EBITDA announcement and discussion of growth projects comes after a sharp re-rating, with the share price showing a 30 day share price return of 7.38% and a 90 day share price...

The Australian Competition and Consumer Commission recently granted interim authorisation for Qantas Airways and American Airlines to continue their joint business on trans-Pacific routes for up to five years while a full competition review is undertaken. This temporary approval removes immediate uncertainty around a key international partnership for Qantas, stabilising flight coordination and customer arrangements across Australia–New Zealand–North America corridors. We’ll now examine how...

Breville Group Limited recently disclosed that State Street Global Advisors and related State Street Corporation subsidiaries have, in the past, ceased to be substantial shareholders in the company, reducing their influence over Breville’s register and governance. This change in the shareholder base could reshape which institutional investors hold sway over Breville’s capital allocation priorities and oversight. We’ll now explore how State Street’s exit as a substantial shareholder may...

Leadership change puts Perenti (ASX:PRN) in focus Perenti (ASX:PRN) has come onto investors’ radar after appointing Dr Vanessa Torres as its new Managing Director and CEO, a planned leadership change that the market initially greeted with a 4.1% share price rise. See our latest analysis for Perenti. That initial reaction sits against a tougher near term backdrop, with a 30 day share price return of 15.2% and a 90 day share price return of 31.7%. At the same time, the 1 year total shareholder...

Why Zip Co’s latest buy back is drawing fresh attention Zip Co (ASX:ZIP) has accelerated its on market share buy back, purchasing more than 1,586,860 shares on 1 April as part of an ongoing capital management effort that is attracting renewed investor interest. See our latest analysis for Zip Co. The buy back follows a sharp 52.99% decline in the 90 day share price return to A$1.575. However, the 1 year total shareholder return of 22.57% and 3 year total shareholder return of 197.17% remain...

Why the CE Mark and equity raise matter for 4DMedical The trigger for 4DMedical (ASX:4DX) is the CE Mark approval for its CT:VQ imaging technology, which opens commercial use across the European Union and highlights a new phase for the company’s respiratory imaging ambitions. This certification arrives alongside an A$83.0 million follow-on equity offering at A$5.90 per share, suggesting 4DMedical is pairing European market access with fresh capital to support CT:VQ deployment and broader...

In late March 2026, filings showed that State Street and its affiliates, along with Vanguard Group, exited their substantial shareholdings in SRG Global, reducing their voting power below major shareholder thresholds and reshaping the company’s institutional register. This withdrawal by two large institutional investors shifts influence toward remaining shareholders, raising questions about how changing ownership might affect SRG Global’s governance and risk perception. We’ll now examine how...

Arafura Rare Earths (ASX:ARU) has secured approximately A$230 million in cornerstone equity subscriptions from Export Finance Australia and the German Raw Materials Fund, marking a key funding step for its Nolans rare earths project in the Northern Territory. See our latest analysis for Arafura Rare Earths. That government backed equity injection has arrived after a period of strong momentum, with a 30 day share price return of 17.65% and a 1 year total shareholder return of 93.55%. However,...

Beach Energy (ASX:BPT) has moved into focus after CEO Brett Woods criticised the Albanese government’s proposed domestic gas reservation scheme, arguing it risks distorting competition and disrupting existing LNG supply chains. See our latest analysis for Beach Energy. At a share price of A$1.305, Beach Energy has recorded a 13.97% 1 month share price return and an 11.08% 1 year total shareholder return. However, the 5 year total shareholder return of an 11.07% decline suggests longer term...

Why AFIC’s buy-back and NTA update matter for investors Australian Foundation Investment (ASX:AFI) is actively buying back its own shares, with more than 8.5 million already repurchased, while also updating investors on its latest net tangible asset backing per share. See our latest analysis for Australian Foundation Investment. AFIC’s ongoing buy-back and recent NTA update come against a softer share price backdrop, with a 30-day share price return decline of 3.24% and a 90-day share price...

Wondering if Life360 at A$18.70 is priced for its potential or already reflecting high expectations? This article breaks down what the current share price may be implying about the company. The stock has seen mixed returns, with a 3.1% decline over the past week and an 8.2% decline over the past month, but a 3.8% gain over the past year and very large gains over the last 3 years and 5 years. Recent moves in the share price sit against this longer track record, which may leave you wondering...

Why Sims shares are under pressure after upbeat guidance Sims (ASX:SGM) issued bullish fiscal 2026 earnings guidance and outlined asset moves, including buying TCT assets and selling its Mayo Shell property, yet the share price has dropped 15% over the last four sessions. See our latest analysis for Sims. The recent 15% slide over four sessions sits against a flat 90 day share price return of 0.99% and a 1 year total shareholder return of 41.53%. This suggests long term momentum while short...

Why Dateline Resources raised A$50 million now Dateline Resources (ASX:DTR) has completed a A$50 million follow-on equity offering at A$0.40 per share, a move that directly affects existing shareholders through both new capital and dilution. See our latest analysis for Dateline Resources. The A$0.40 offer price came at a discount to the latest A$0.405 share price. The stock has seen a 9.5% 30 day share price return alongside an 84.1% 90 day share price return, while the 1 year total...

Magellan Financial Group (ASX:MFG) recently completed an oversubscribed A$20 million Share Purchase Plan, issuing about 2.37 million new shares and drawing fresh attention to how this capital raise could affect investors. See our latest analysis for Magellan Financial Group. The oversubscribed Share Purchase Plan and recent follow-on equity offering have arrived alongside some cooling in momentum, with a 1 day share price return decline of 4.89% and a 1 year total shareholder return of...

Mayfield Group Holdings Limited ( ASX:MYG ), is not the largest company out there, but it saw a double-digit share...

With the business potentially at an important milestone, we thought we'd take a closer look at AML3D Limited's...

Metallium Limited ( ASX:MTM ) is possibly approaching a major achievement in its business, so we would like to shine...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Why the Kwinana decision matters for AGL Energy shares AGL Energy (ASX:AGL) has approved a A$490 million gas fired power station at Kwinana in Western Australia, a project aimed at providing firming capacity to support renewable integration and secure capacity revenues. See our latest analysis for AGL Energy. AGL Energy shares trade at A$9.92, with a 30 day share price return of 3.23% and a 90 day share price return of 6.32%. The 3 year total shareholder return of 39.63% contrasts with a...

Resolute Mining Limited and Nimba Mining Company S.A., with the support of Guinea’s Ministry of Mines and Geology, recently signed a non-binding Memorandum of Understanding to jointly assess and potentially co-develop gold projects in one of West Africa’s most prospective gold regions. This agreement marks Nimba Mining Company’s first collaboration with a listed international gold producer and could lay the groundwork for a joint venture structure focused on responsible, large-scale gold...

Why IperionX is back on investors’ radar IperionX (ASX:IPX) has started commercial production at its Virginia titanium facility, while director Todd Hannigan recently bought 225,225 shares in an A$721,000 transaction, drawing fresh attention to the stock. See our latest analysis for IperionX. The recent move into commercial production and the A$721,000 insider purchase come after a sharp 45.62% 1 month share price decline and a 34.54% year to date share price return. However, the 1 year total...